Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against Gram negative bacteria

Indian Journal of Medical Research

Volumn 122, Issue 5, 2005, Pages 425-428

  Mohanty, Srujana ^a   Singhal, Ritu ^a   Sood, Seema ^a   Dhawan, Benu ^a   Das, Bimal K ^a   Kapil, Arti ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Beta lactam beta lactamase inhibitors; Cefoperazone sulbactam; Extended spectrum beta lactamase; Piperacillin tazobactam; Ticarcillin clavulanic acid

Indexed keywords

AMIKACIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; TIMENTIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DIFFUSION; DRUG EFFICACY; ENZYME SYNTHESIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOSPITAL ADMISSION; HUMAN; IN VITRO STUDY; INDIA; KLEBSIELLA; NONHUMAN; PSEUDOMONAS;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEFOPERAZONE; CLAVULANIC ACIDS; CROSS INFECTION; GRAM-NEGATIVE BACTERIA; HUMANS; PENICILLANIC ACID; PIPERACILLIN; SULBACTAM; TICARCILLIN;

EID: 33144478944     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bradley JS, Arrieta A. Empiric use of cefepime in the treatment of lower respiratory tract infections in children. Pediatric Infect Dis J 2001; 20 : 343-9.
2. Miller LA, Ratnam K, Payne DJ. β-lactamase-inhibitor combinations in the 21st century: current agents and new developments. Curr Opin Pharmacol 2001; 1 : 451-8.
3. Mohanty S, Kapil A, Dhawan B, Das BK. Bacteriological and antimicrobial susceptibility profile of soft tissue infections from northern India. Indian J Med Sci 2004; 58 : 10-5.
4. Mohanty S, Kapil A, Das BK, Dhawan B. Antimicrobial resistance profile of nosocomial uropathogens in a tertiary care hospital. Indian J Med Sci 2003; 57 : 148-54.
5. Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum β lactamase producing Gram negative bacteria in a tertiary care hospital. Indian J Med Res 2002; 115 : 153-7.
6. Collee JG, Miles RS, Wan B. Tests for the identification of bacteria. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie and McCartney practical medical microbiology, 14th ed. Edinburgh: Churchill Livingstone; 1996 p. 131-50.
7. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility testing. Twelfth informational supplement (M100-S12). 2002. Wayne PA: NCCLS.
8. Frank U, Mutter J, Schmidt-Eisenlohr E, Daschner FD. Comparative in vitro activity of piperacillin, piperacillin-sulbactam and piperacillin- tazobactam against nosocomial pathogens isolated from intensive care patients. Clin Microbiol Infect 2003; 9 : 1128-32.
9. Higgins PG, Wisplinghoff H, Stefanik D, Seifert H. In vitro activities of the β-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with -lactam against epidemiologically characterized multidrug resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother 2004; 48 : 1586-92.
10. Pandey A, Kapil A, Sood S, Goel V, Das B, Seth P. In vitro activities of ampicillin-sulbactam and amoxicillin-clavulanic acid against Acinetobacter baumannii. J Clin Microbiol 1998; 36 : 3415-6.
11. Hou F, Li J, Gao L, Chen Y. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections. Chin Med J (Engl) 1998; 111 : 1039-43.
12. Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999; 159 : 2562-72.
13. Navaneeth BV, Sridaran D, Sahay D, Belwadi MRS. A preliminary study on metallo-β-lactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med Res 2002; 116 : 264-7.
14. Chitnis SV, Chitnis V, Sharma N, Chitnis DS. Current status of drug resistance among Gram-negative bacilli isolated from admitted cases in a tertiary care centre. J Assoc Physicians India 2003; 51 : 28-32.